Core Points - Igor is advancing its internationalization strategy by planning to issue H shares and apply for listing on the Hong Kong Stock Exchange [1][3] - The company held its seventh board meeting on November 24, where it approved the proposals for issuing H shares and listing on the Hong Kong Stock Exchange [3] - As of the announcement date, Igor is actively working with intermediaries to facilitate the issuance and listing process, with further details to be discussed [3] Company Overview - Igor was established in October 1999 and was listed on the Shenzhen Stock Exchange in December 2017 [3] - The company focuses on the research, development, production, and sales of power supply and power component products for industrial and consumer sectors [3] - Igor specializes in energy and information industries, utilizing power electronics technology, with applications in photovoltaic power generation, industrial control, and data centers [3] Industry Context - As of now, 12 photovoltaic companies have announced plans to list in Hong Kong, including leading firms like JA Solar and Sungrow Power [3] - JunDa Co. has already successfully listed on the Hong Kong Stock Exchange in May 2023 [4] - A detailed list of companies planning to list in Hong Kong includes various firms with different stages of the listing process [5]

Group 1 - Nanjing has seen a surge in companies applying for listings on the Hong Kong Stock Exchange, with 13 companies currently in the queue [2][8] - Notable companies that have successfully listed include Yaojie Ankang and Nanjing Weili Zhibo, both in the biopharmaceutical sector [2][11] - The industrial robot sector in Nanjing is thriving, with Estun Automation leading the market with a 10.5% share, contributing to a domestic robot market growth [4][6] Group 2 - Estun Automation plans to issue H-shares and has submitted its listing application to the Hong Kong Stock Exchange, marking a significant step in its global capital strategy [6][7] - Four-dimensional Intelligent Technology also submitted its prospectus on the same day as Estun, indicating a strong interest in the Hong Kong market [6][7] - The Nanjing Jiangbei New Area has been particularly active in fostering innovative pharmaceutical companies, with multiple firms successfully listing or applying for listings [9][13] Group 3 - The Jiangbei New Area has implemented supportive policies to assist companies in their overseas listing efforts, including a 1 billion yuan investment fund for companies planning to list abroad [15] - The collaboration between Nanjing's municipal financial office and the Hong Kong Stock Exchange has enhanced the capital market cooperation, leading to an increase in new listings [15]

Core Viewpoint - Transsion Holdings plans to issue H-shares and list them within 24 months following the shareholders' meeting resolution, amid previous market speculation about a potential Hong Kong listing [2][4] Group 1: Company Overview - Transsion Holdings is recognized as the "King of African Mobile Phones," being one of the first domestic smartphone manufacturers to enter the African market [4] - The company has established manufacturing centers in Ethiopia, India, and Bangladesh, with products available in over 70 countries and regions globally [4] - According to IDC data, Transsion Holdings holds an 8.6% market share in the global smartphone market for 2024, ranking fourth, and leads in smartphone shipments in Africa, Pakistan, Bangladesh, and the Philippines [4] Group 2: Financial Performance - For the first three quarters of the year, Transsion Holdings reported revenue of 49.54 billion yuan, a year-on-year decline of 3.33%, and a net profit of 2.148 billion yuan, down 44.97% year-on-year [4] - In the third quarter, the company experienced a revenue increase of 22.6% year-on-year, but net profit decreased by 11.06% [4] - The decline in net profit is attributed to market competition and supply chain cost impacts, leading to a decrease in gross margin [4] Group 3: Future Plans - The company intends to adjust pricing and product structure in response to cost changes and market competition to maintain a healthy gross margin [4] - The issuance of H-shares and listing is subject to approval from the shareholders' meeting and relevant regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [4] - Transsion Holdings is actively discussing the details of the H-share issuance and listing with relevant intermediaries [4] Group 4: Industry Context - Transsion Holdings is part of a broader trend of A-share consumer electronics companies pursuing listings in Hong Kong, following others like Lens Technology, Lixun Precision, and GoerTek [5]

Core Insights - The event "Rongyi Shang" aimed at facilitating Chengdu enterprises to go public in Hong Kong was recently held, supported by Deloitte China and attended by over 300 representatives from various sectors [1][2] Group 1: Event Overview - The event was organized by the Chengdu Municipal Committee Financial Committee Office and aimed to accelerate the pace of Chengdu enterprises going public in Hong Kong, particularly in the biomedicine, technology, and consumer sectors [1] - Deloitte China, along with other supporting institutions, provided expertise on the Hong Kong listing process, helping local companies expand their overseas financing channels [1][2] Group 2: Expert Contributions - Deloitte China sent four listing experts to share insights on key considerations for Hong Kong listings, including the listing hearing process and critical steps for biomedicine, technology, and consumer companies [2] - Key speakers included representatives from various regulatory and intermediary institutions from both Hong Kong and mainland China, who provided guidance on preparing for Hong Kong listings [1][2] Group 3: Key Considerations for Listing - The focus of the discussions included the importance of financial compliance, internal controls, and clear governance structures to enhance the likelihood of successful listings [6][7] - Specific challenges faced by biomedicine companies in financial preparations for Hong Kong listings were highlighted, emphasizing the need for thorough financial work [9] - Financial concerns for technology and consumer companies were also addressed, with particular attention to revenue recognition, data verification, and industry-specific disclosure rules [11]

Group 1: Hong Kong Capital Market Overview - In the first three quarters of 2025, Hong Kong's capital market led globally with 67 IPOs and a fundraising amount of HKD 186.5 billion, representing a year-on-year increase of 236% [1] - By the end of September, net inflows from southbound funds reached HKD 116.8 billion, surpassing the total for 2024 and showing a significant year-on-year growth of nearly 132% [1] - The influx of long-term capital from international sources, including the US and the Middle East, has driven the average daily trading volume of Hong Kong stocks to a historical high, with IPO companies achieving the strongest post-market performance since 2020 [1] Group 2: EY's Role and Initiatives - EY launched a series of forums in eight cities along the Yangtze River, focusing on practical challenges and execution details in the IPO process, reflecting the demand for professional guidance amid the Hong Kong IPO boom [2][5] - The forums featured discussions on opportunities and practical aspects of listing in Hong Kong, with participation from notable investment banks, law firms, and EY partners [2][5] - EY emphasized its commitment to supporting clients in achieving their IPO goals, highlighting the importance of integrating professional services and financial support for successful listings [5] Group 3: Key Insights from the Forums - Experts discussed the need for companies to establish clear financial logic and data support systems, as well as to conduct tax health checks and optimize tax planning early in the IPO process [3][6] - Legal challenges related to overseas listings were analyzed, with recommendations for companies to implement a dual compliance mechanism to ensure legal stability throughout the process [3][6] - The forums provided a platform for interactive discussions, allowing participants to gain a comprehensive understanding of the IPO framework and critical milestones [3][10] Group 4: Future Events and Engagement - EY announced the continuation of the "China Enterprises Going Public in Hong Kong" forums in key cities, aiming to expand service coverage and deepen regional cooperation [11] - Upcoming events are scheduled in Suzhou, Chengdu, Ningbo, and Hefei, with specific dates and locations provided for interested participants [11]

Group 1 - Minglue Technology from Sichuan Province has successfully listed on the Hong Kong stock market, becoming the second company from the province to do so this year [1] - The Hong Kong stock market has become a popular listing destination due to policy support and a recovering funding environment, with over HKD 210 billion raised in the first ten months of the year, ranking first globally [1] - The total IPO financing amount in Hong Kong has reached HKD 216.47 billion this year, representing a year-on-year increase of 203.5%, with 81 companies listed, a 50% increase compared to last year [1] Group 2 - Strategic emerging industries, particularly in healthcare and information technology, have become the mainstay of the Hong Kong IPO market this year [2] - The pharmaceutical and biotechnology sector has seen the highest number of listings, with 17 companies raising HKD 24.23 billion, including major IPOs from companies like Hengrui Medicine and Jinfang Pharmaceutical [2] - A record 58 pharmaceutical companies have submitted applications for IPOs in Hong Kong this year, with nearly 70% focusing on innovative drug development in oncology and autoimmune diseases [2] Group 3 - In the industrial engineering and software service sectors, 11 and 7 companies have gone public this year, raising HKD 77.92 billion and HKD 12.03 billion respectively [3] - The industrial engineering sector has fewer IPOs but larger individual fundraising amounts, with SANY Heavy Industry raising over HKD 10 billion [3] - In the software service sector, companies like Hesai Technology and Cambridge Technology have each raised over HKD 4 billion [3] Group 4 - Shanghai, Guangdong, Jiangsu, and Zhejiang lead in the number of companies listed on the Hong Kong stock market this year, with Shanghai having 14 listings [4] - Notable companies from Shanghai include Cambridge Technology and Hohhot Aunt, covering various sectors such as hard technology and consumer upgrades [4] - Shenzhen has also seen significant listings, with companies like Guanghetong and Xipuni focusing on high-end manufacturing and smart technology [4] Group 5 - Local governments are prioritizing support for companies going public in Hong Kong, offering services such as financial subsidies and one-stop consulting to reduce compliance and financing costs [5] - Initiatives like Chengdu's "Rongqi Outbound" program and Shenzhen's comprehensive support mechanism are designed to facilitate the listing process for companies [5]

Core Viewpoint - Shenzhen's new merger and acquisition policy aims to support qualified companies in pursuing high-quality development through mergers and acquisitions, with a target of exceeding a total market value of 20 trillion yuan for listed companies by the end of 2027 and cultivating 20 companies with a market value of over 100 billion yuan [1][2]. Group 1: Policy Initiatives - The action plan includes measures to connect with Hong Kong's capital market, facilitating cross-border mergers and acquisitions [1]. - Specific initiatives involve supporting leading enterprises in Shenzhen to list or refinance in Hong Kong, establishing equity investment funds for industrial mergers, and enhancing cooperation between Shenzhen Stock Exchange and Hong Kong Stock Exchange [1][2]. - The policy is a continuation of the central government's push for deeper financial cooperation between Shenzhen and Hong Kong, as highlighted in a June 2023 document [1][2]. Group 2: Market Response - Following the announcement of the new policy, the Shenzhen state-owned assets sector experienced a surge, with stocks hitting the daily limit on the first trading day [2]. - Over 70 mainland companies have listed in Hong Kong this year, raising over 190 billion HKD, with many from Shenzhen in sectors like consumer electronics and biotechnology [2][3]. Group 3: Support for Enterprises - Shenzhen's government is committed to providing comprehensive support for local companies looking to list in Hong Kong, including a full-cycle service mechanism for companies in various districts [3][4]. - The Hong Kong government has also prioritized attracting mainland companies to list in Hong Kong, with initiatives to assist tech firms in financing [3][4]. Group 4: Challenges and Opportunities - Experts note that while the integration of Shenzhen and Hong Kong's financial markets presents opportunities, there are still systemic barriers to overcome, such as discrepancies in listing rules and compliance standards [5]. - A clearer and more stable policy environment is needed to reduce compliance costs and enhance financing efficiency for companies [5].

Core Viewpoint - Hong Kong is experiencing a listing boom, with companies like Baile Tianheng preparing for their IPOs, reflecting a strong interest from Chengdu enterprises in accessing international capital markets [1][8]. Group 1: Market Activity - Baile Tianheng has passed the listing hearing on the Hong Kong Stock Exchange, with Chengdu's total number of listed companies expected to reach 28 [1]. - Numerous institutions and enterprises actively participated in the "Rongyi Shang" event, indicating a high level of interest in Hong Kong listings [3]. - The scale of participation in the event this year has significantly increased compared to last year, showcasing the enthusiasm of Chengdu enterprises for listing in Hong Kong [3]. Group 2: Sector Insights - The event featured specialized sessions for biopharmaceutical and technology/consumer sectors, with over a hundred representatives from enterprises and financial institutions attending [3][5]. - Key insights were shared regarding the opportunities and challenges faced by companies seeking to list in Hong Kong, particularly in the biopharmaceutical sector [5][7]. - Legal experts discussed critical points encountered by enterprises during the listing process, emphasizing the importance of legal support for technology and consumer companies [5]. Group 3: Investment Opportunities - Investment institutions highlighted the opportunities presented by listing in Hong Kong, particularly for Chengdu enterprises looking to expand internationally [8]. - Several Chengdu companies, including Guoxing Aerospace and Xinyue Holdings, have submitted applications for Hong Kong listings this year, indicating a trend of local firms seeking to leverage international capital markets [8]. - As of now, Chengdu has 122 A-share listed companies, 27 listed in Hong Kong, and 5 in the US, with the total expected to reach 154 following Baile Tianheng's listing [8].

Core Viewpoint - Bailitianheng has successfully passed the listing hearing on the Hong Kong Stock Exchange, marking a significant step towards its IPO, which will increase the number of listed companies from Chengdu to 28 [1][5]. Company Developments - Bailitianheng is recognized as a leading domestic innovative drug company, with notable achievements in the field of innovative drug development and international expansion [4]. - The company announced that its self-developed innovative biological drug, BL-M24D1 (ADC), has received approval for clinical trials from the National Medical Products Administration [4]. - Bailitianheng has launched a fundraising plan to raise 3.764 billion yuan, which will be entirely allocated to the development of innovative drugs, particularly to accelerate clinical trials for core ADC products [4]. Financial Partnerships - In December 2023, Bailitianheng entered into a collaboration agreement with Bristol-Myers Squibb (BMS) for the dual-target ADC drug BL-B01D1, with a potential total transaction value of $8.3 billion, including an upfront payment of $800 million [6]. - The company is expected to receive milestone payments from BMS, which could total $1.05 billion (approximately 7.5 billion yuan) if all conditions are met [6]. Industry Trends - The trend of companies from Chengdu seeking listings in Hong Kong reflects a strong momentum for local enterprises to expand into international capital markets [8]. - As of now, Chengdu has 122 A-share listed companies, 27 listed in Hong Kong, and 5 in the US, with the total number of listed companies expected to reach 154 following Bailitianheng's IPO [8].

Group 1 - The global economic landscape is undergoing significant adjustments, with China's economy demonstrating resilience and vitality. Hong Kong's status as a core hub connecting mainland China with global capital markets is increasingly prominent [2] - As of the end of September 2025, Hong Kong has seen nearly 70 IPOs in the first three quarters, raising approximately HKD 183 billion, representing a year-on-year increase of 228%, making it the largest financing hub globally [2] - The trend of Chinese companies listing in Hong Kong is becoming a strategic choice for expanding international financing channels, enhancing global brand influence, and optimizing corporate governance [2] Group 2 - Ernst & Young (EY) is recognized as a leading professional services firm with extensive experience in assisting companies with listings in Hong Kong, providing comprehensive support for cross-border financing [2] - A series of forums will be held in various cities to address key concerns and practical challenges related to listing in Hong Kong, including insights into the latest listing policies, market trends, regulatory requirements, and critical points in the IPO process [3] - The forums aim to create an efficient platform for communication and collaboration, bringing together regulatory representatives, stock exchange officials, and professionals from various sectors to share insights and solutions [3] Group 3 - Specific details of the forums include dates and locations in cities such as Hangzhou, Shanghai, Ningbo, Suzhou, and Chengdu, with contact persons provided for each event [4]